Does anyone else find it bazaar that studies of first hundreds and now thousands of Covid-19 patients showing the benefits of treatment with an old, inexpensive, readily available, well know drug is met with skepticism by the media, while early results of 8 healthy young people for a new, expensive, not yet in production, untried drug is met with positive accolades by the very same media?
Life in the reset